- HCA Healthcare Inc (NYSE:HCA) has reported Q2 FY22 revenues of $14.82 billion, compared to $14.43 billion a year ago, beating the consensus of $14.72 billion.
- EPS of $4.21, lower than the $4.37 reported a year ago, surpasses the estimate of $3.70.
- Net income fell from $1.45 billion to $1.15 billion.
- "Many aspects of our business were positive considering the challenges we faced with the labor market and other inflationary pressures on costs," said Sam Hazen, CEO of HCA Healthcare.
- Same facility admissions decreased 1.2% Y/Y, and equivalent admissions increased 0.5%.
- Same facility revenue per equivalent admission increased 3.5%.
- Same facility emergency room visits increased by 7.3%, inpatient surgeries declined 2.3%, and outpatient surgeries declined 1.4%.
- Adjusted EBITDA totaled $3.04 billion, compared to $3.22 billion in Q2 FY21.
- Dividend: HCA Healthcare declared a quarterly cash dividend of $0.56 per share, payable on September 30, at the record date of September 16.
- Price Action: HCA shares are up 13.24% at $205.31 during the premarket session on the last check Friday.
Loading...
Loading...
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
